Evidence map›Paper›PMID 40478616›Full record

ArticleJournal of medical Internet research2025

Experiences of Using a Digital Text Messaging Intervention to Support Oral Medication Adherence for People Living With Type 2 Diabetes: Qualitative Process Evaluation.

Nikki Newhouse, Yvonne Kiera Bartlett, Sara Correia Simao, Lisa Miles, Rachel Cholerton, Cassandra Kenning, Louise Locock, Veronika Williams, David P French, Rustam Rea and 1 more

Abstract readEvaluation Study
In one paragraph

Article in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nikki NewhouseNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.ORCID https://orcid.org/0000-0001-9002-3588
Yvonne Kiera BartlettManchester Centre for Health Psychology, School of Health Sciences, University of Manchester, Manchester, United Kingdom.ORCID https://orcid.org/0000-0002-5913-3014
Sara Correia SimaoManchester Centre for Health Psychology, School of Health Sciences, University of Manchester, Manchester, United Kingdom.ORCID https://orcid.org/0000-0002-7441-1350
Lisa MilesManchester Centre for Health Psychology, School of Health Sciences, University of Manchester, Manchester, United Kingdom.ORCID https://orcid.org/0000-0002-8971-125X
Rachel CholertonManchester Centre for Health Psychology, School of Health Sciences, University of Manchester, Manchester, United Kingdom.ORCID https://orcid.org/0000-0002-6440-8537
Cassandra KenningManchester Centre for Health Psychology, School of Health Sciences, University of Manchester, Manchester, United Kingdom.ORCID https://orcid.org/0000-0001-6041-4051
Louise LocockAberdeen Centre for Evaluation (formerly Health Services Research Unit), University of Aberdeen, Aberdeen, United Kingdom.ORCID https://orcid.org/0000-0002-8109-1930
Veronika WilliamsSchool of Nursing, Nipissing University, Ontario, ON, Canada.ORCID https://orcid.org/0000-0001-5660-8224
David P FrenchManchester Centre for Health Psychology, School of Health Sciences, University of Manchester, Manchester, United Kingdom.ORCID https://orcid.org/0000-0002-7663-7804
Rustam ReaOxford Centre for Diabetes, Endocrinology and Metabolism, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.ORCID https://orcid.org/0000-0001-6515-8325
Andrew FarmerNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.ORCID https://orcid.org/0000-0002-6170-4402

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPoor adherence to oral medications for type 2 diabetes can increase the risk of health complications. Digital interventions can affect people's experiences of self-managing a chronic condition, and SMS text messages may provide an effective delivery method for an intervention. The Support Through Mobile Messaging and Digital Health Technology for Diabetes (SuMMiT-D) intervention uses evidence-based SMS text messages to support people with type 2 diabetes with regular and consistent use of diabetes medication.

objectiveThis process analysis, conducted alongside a randomized controlled trial of SuMMiT-D, aimed to explore (1) the contextual factors that may interact with the SuMMiT-D intervention and (2) the self-reported mechanisms through which change in behavior or attitude might occur.

methodsA nested qualitative process study was conducted within primary care in England. A total of 43 trial participants diagnosed with type 2 diabetes were assigned to receive the SuMMiT-D intervention, were undergoing oral glucose-lowering treatment, blood pressure-lowering treatment or lipid-lowering treatment, either alone or in combination, and had access to a mobile phone, took part in semistructured telephone interviews. Data were analyzed using inductive thematic analysis.

resultsIn total, 2 overarching themes were developed exploring relevant contextual factors and potential mechanisms of change. The system exerted a range of holistic benefits and supported the cognitions, beliefs, and behaviors necessary for longitudinal self-management. The perceived value of the messages was fluid and linked to contextual need. Appraisal of the system was influenced by existing routines, lifestyle disruption, people's understanding of type 2 diabetes, relationships with other people, and subjective attitudes toward living with type 2 diabetes in contemporary society.

conclusionsThis work demonstrates the value of engaging people longitudinally in thinking about their general health, the importance of interrogating context, and the holistic benefit of health messaging. Many people perceived wide-ranging and unexpected benefits from using the intervention over time, challenging assumptions about who might be expected to appraise the system more positively and who should be offered access to it.

Indexed as

Diabetes Mellitus, Type 2Medication AdherenceText MessagingAdministration, OralAgedFemaleHumansHypoglycemic AgentsMaleMiddle AgedQualitative ResearchRandomized Controlled Trials as TopicHypoglycemic Agentshealth-related behaviormHealthmobile healthmobile phonequalitative studySMStype 2 diabetes

Identifiers

PMID40478616
PMCPMC12181749

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.